ID26083A - 10-KAMFORSULFONATE PAROXOXINE FOR TREATMENT OF CNS INTERFERENCE - Google Patents

10-KAMFORSULFONATE PAROXOXINE FOR TREATMENT OF CNS INTERFERENCE

Info

Publication number
ID26083A
ID26083A IDW20002168A ID20002168A ID26083A ID 26083 A ID26083 A ID 26083A ID W20002168 A IDW20002168 A ID W20002168A ID 20002168 A ID20002168 A ID 20002168A ID 26083 A ID26083 A ID 26083A
Authority
ID
Indonesia
Prior art keywords
paroxoxine
kamforsulfonate
cns
interference
treatment
Prior art date
Application number
IDW20002168A
Other languages
Indonesian (id)
Inventor
Michael Urquhart
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of ID26083A publication Critical patent/ID26083A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IDW20002168A 1998-04-25 1999-04-23 10-KAMFORSULFONATE PAROXOXINE FOR TREATMENT OF CNS INTERFERENCE ID26083A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9808896.6A GB9808896D0 (en) 1998-04-25 1998-04-25 Novel compound

Publications (1)

Publication Number Publication Date
ID26083A true ID26083A (en) 2000-11-23

Family

ID=10831008

Family Applications (2)

Application Number Title Priority Date Filing Date
IDW20002169A ID26654A (en) 1998-04-25 1999-04-23 ASCORBATE PAROXCETINS
IDW20002168A ID26083A (en) 1998-04-25 1999-04-23 10-KAMFORSULFONATE PAROXOXINE FOR TREATMENT OF CNS INTERFERENCE

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IDW20002169A ID26654A (en) 1998-04-25 1999-04-23 ASCORBATE PAROXCETINS

Country Status (20)

Country Link
EP (1) EP1089995A1 (en)
JP (1) JP2002513019A (en)
KR (1) KR20010042977A (en)
CN (1) CN1297448A (en)
AP (1) AP2000001963A0 (en)
AU (1) AU3618499A (en)
BG (1) BG104940A (en)
BR (1) BR9909868A (en)
CA (1) CA2330055A1 (en)
EA (1) EA200001104A1 (en)
GB (1) GB9808896D0 (en)
HU (1) HUP0102116A3 (en)
ID (2) ID26654A (en)
IL (1) IL139081A0 (en)
NO (1) NO20005352L (en)
PL (1) PL343677A1 (en)
SK (1) SK15912000A3 (en)
TR (1) TR200003084T2 (en)
WO (1) WO1999055698A1 (en)
ZA (1) ZA200005912B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
IL159280A0 (en) * 2001-06-14 2004-06-01 Teva Pharma A process for preparing paroxetine hcl which limits formation of pink colored compounds
ES2664189T3 (en) * 2002-01-09 2018-04-18 Emisphere Technologies, Inc. Sodium 4- (4-Chloro-2-hydroxybenzoyl) aminobutanoate polymorphs
CN110607555B (en) * 2018-10-30 2024-02-20 中国科学院化学研究所 Method for preparing taxol monocrystal or amorphous substance

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
DE3688827T2 (en) * 1985-10-25 1994-03-31 Beecham Group Plc Piperidine derivative, its manufacture and its use as a medicine.
US5276042A (en) * 1993-04-16 1994-01-04 Crenshaw Roger T Treatment of premature ejaculation
ES2117557B1 (en) * 1996-02-29 1999-07-01 Ferrer Int NEW PROCEDURE FOR OBTAINING (-) - TRANS -N-P-FLUOROBENZOILMETIL-4- (P-FLUOROFENIL) -3- ((3,4- (METHYLENDIOXI) PHENOXI) METHYL) -PIPERIDINE.

Also Published As

Publication number Publication date
BR9909868A (en) 2000-12-19
JP2002513019A (en) 2002-05-08
KR20010042977A (en) 2001-05-25
HUP0102116A2 (en) 2002-05-29
BG104940A (en) 2001-09-28
TR200003084T2 (en) 2001-02-21
GB9808896D0 (en) 1998-06-24
CA2330055A1 (en) 1999-11-04
EA200001104A1 (en) 2001-04-23
ID26654A (en) 2001-01-25
NO20005352D0 (en) 2000-10-24
AP2000001963A0 (en) 2000-12-31
NO20005352L (en) 2000-10-24
AU3618499A (en) 1999-11-16
PL343677A1 (en) 2001-08-27
WO1999055698A1 (en) 1999-11-04
CN1297448A (en) 2001-05-30
ZA200005912B (en) 2001-12-19
SK15912000A3 (en) 2001-04-09
IL139081A0 (en) 2001-11-25
EP1089995A1 (en) 2001-04-11
HUP0102116A3 (en) 2002-12-28

Similar Documents

Publication Publication Date Title
NO20012995D0 (en) Compound useful for treating inflammatory diseases
ID24638A (en) COMPOUNDS OF ANTI ARYTHMIA BISPIDINA
ID27191A (en) METHODS FOR TREATMENT OF INSOMNIA
NO20003065L (en) Combination for effective treatment of impotence
ID26990A (en) METHOD OF MAKING DIMETHYLNAFTALENA
ID25901A (en) PROCESS OF MAKING 4-AMINOMETHYL-PYROLIDINE-3-ON PROTECTED
ID27214A (en) TRIAZOLOPIRIDINA FOR TREATMENT OF TROMBOSIS DISORDERS
ID17723A (en) COMPOUND FOR TREATMENT
IS4789A (en) treatment Compounds
ID28032A (en) TRICICLIC OF PIPERIDIN-Δ3-AS ANTAGONIS-α2
NO20003211D0 (en) Triazine compounds for the treatment of CNS disorders
ID26083A (en) 10-KAMFORSULFONATE PAROXOXINE FOR TREATMENT OF CNS INTERFERENCE
NO20003481D0 (en) Procedure for the treatment of COPD
NO20012099D0 (en) Process for the preparation of 4-arylpiperidine-3-carbinols and related compounds
ID21920A (en) 4-6-FLUORO- (1H) -INDOL-3-IL-1,2,3,6-TETRAH HYDROPIRINS SUBSTITUTED FOR TREATMENT OF CNS INTERFERENCE
PT1175417E (en) SUBSTITUTED COMPOUNDS OF BENZOLACTAMAS
NO20006383L (en) Process of treatment
PT1088010E (en) PRODUCTION OF POLYOLEFINS
IL126681A0 (en) Treatment of trauma-related conditions
IL138843A0 (en) Improved process for the manufacture of n- (1-cyanoalkyl) -2-phenoxypropionamide derivatives
FI981803A0 (en) Method for preventing the formation of precipitates
NO20012301D0 (en) New procedure for treatment
NO20006382D0 (en) Method of treating organophosphate poisoning
NO20005351D0 (en) Paroxetine 10-camphor sulfonate for the treatment of CNS disorders
NO996166D0 (en) Process for the treatment of odluor